Emerging risks | Growth Opportunities | APAC Insurance

Thursday, November 5, 2026

Analysis, Asset intensive reinsurance, Capital adequacy, Capital management, Life, Life and Health, News, Reinsurance

Japan solvency reforms drive cessions as AM Best maintains stable outlook for global life reinsurance

Improving mortality experience and the growing influence of GLP‑1 drugs are reshaping life reinsurance pricing and underwriting assumptions.

By

Reih Angeles

September 3, 2026

•

3 min read

(Re)in AsiaSIRC 2026 Hub

(Re)in AsiaSIRC 2026HubExplore the hub →

Unlock this insight for free

Register for a free 14-day trial to read the full insight.

14 days of access to (Re)in Asia’s premium intelligence
Free daily briefing in your inbox each morning
No credit card required

Already have an account? Sign in →

(Re)in AsiaSIRC 2026 Hub

(Re)in AsiaSIRC 2026HubExplore the hub →

Read next

Regulatory reforms support stable outlook for China's non-life insurers: AM Best September 8 2026
Indonesia health, credit lines remain pressure points as AM Best keeps non-life outlook stable October 8 2026
Moody's upgrades China life insurance outlook to stable on profitability, capital strength October 29 2026
Samsung Life to raise US$1.5bn through offshore hybrid bond to strengthen solvency October 12 2026
AIA maintains earnings outlook as third-quarter new business value falls 5% October 30 2026
Japan urges non-life insurers to review agency terminations amid quality reforms October 15 2026